Molecular mimicry in the etiology of autoimmune diseases;Rola mimikry molekularnej w etiologii schorzeń o charakterze autoimmunizacyjnym

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 66, Issue , 2012, Pages 475-491

  Lis, Jolanta ^a   Jarza̧b, Anna ^a   Witkowska, Danuta ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Autoimmune diseases; Autoimmunity; Diabetes type 1; Molecular mimicry; Multiple sclerosis; Reactive arthritis

Indexed keywords

EID: 84867925598     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1003484     Document Type: Review

References (137)

1. Agmon-Levin N., Blank M., Paz Z., Shoenfeld Y.: Molecular mimicry in systemic lupus erythematosus. Lupus, 2009;18:1181-1185
2. Ahn J. H., Jang W. J., Hayward G. S.: The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol., 1999;73:10458-10471
3. Akeno N., Blackard J. T., Tomer Y.: HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J. Autoimmun., 2008;31:339-344
4. Al-Omaishi J., Bashir R., Gendelman H. E.: The cellular immunology of multiple sclerosis. J. Leukoc. Biol., 1999;65:444-452
5. Baekkeskov S., Aanstoot H. J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P.: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature, 1990;347:151-156
6. Bagos P. G., Nikolopoulos G., Ioannidis A.: Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult. Scler., 2006;12:397-411
7. Barten L. J., Allington D. R., Procacci K. A., Rivey M. P.: New approaches in the management of multiple sclerosis. Drug Des. Devel. Ther., 2010;4:343-366
8. Beppu H., Winter W. E., Atkinson M. A., Maclaren N. K., Fujita K., Takahashi H.: Bovine albumin antibodies in NOD mice. Diabetes Res., 1987;6:67-69
9. Berer K., Mues M., Koutrolos M., Rasbi Z. A., Boziki M., Johner C., Wekerle H., Krishnamoorthy G.: Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature, 2011;479:538-541
10. Bertsias G. K., Salmon J. E., Boumpas D. T.: Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann. Rheum. Dis., 2010;69:1603-1611
11. Biernat-Kałuża E.: Reaktywne zapalenie stawów jako interdyscyplinarny problem medyczny. Carol. Med. Center, 2001;3:222-230
12. Blomqvist M., Juhela S., Erkkila S., Korhonen S., Simell T., Kupila A., Vaarala O., Simell O., Knip M., Ilonen J.: Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin. Exp. Immunol., 2002;128:511-515
13. Buljevac D., Verkooyen R. P., Jacobs B. C., Hop W., van der Zwaan L. A., van Doorn P. A., Hintzen R. Q.: Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Ann. Neurol., 2003;54:828-831
14. Cavallo M. G., Fava D., Monetini L., Barone F., Pozzilli P.: Cellmediated immune response to β casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet, 1996;348:926-928
15. Cermenati G., Abbiati F., Cermenati S., Brioschi E., Volonterio A., Cavaletti G., Saez E., De Fabiani E., Crestani M., Garcia-Segura L. M., Melcangi R. C., Caruso D., Mitro N.: Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J. Lipid Res., 2012;53:300-310
16. Challoner P. B., Smith K. T., Parker J. D., MacLeod D. L., Coulter S. N., Rose T. M., Schultz E. R., Bennett J. L., Garber R. L., Chang M., Schad P. A., Stewart P. M., Nowinski R. C., Brown J. P., Burmer G. C.: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA, 1995;92:7440-7444
17. Chen J. Z., Settembre E. C., Aoki S. T., Zhang X., Bellamy A. R., Dormitzer P. R., Harrison S. C., Grigorieff N.: Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proc. Natl. Acad. Sci. USA, 2009;106:10644-10648
18. Cheung R., Karjalainen J., Vandermeulen J., Singal D. P., Dosch H. M.: T cells from children with IDDM are sensitized to bovine serum albumin. Scand. J. Immunol., 1994;40:623-628
19. Christen U., von Herrath M. G.: Initiation of autoimmunity. Curr. Opin. Immunol., 2004;16:759-767
20. Colmegna I., Cuchacovich R., Espinoza L. R.: HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin. Microbiol. Rev., 2004;17:348-369
21. Croxford J. L., Anger H. A., Miller S. D.: Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J. Immunol., 2005;174:907-917
22. Cusick M. F., Libbey J. E., Fujinami R. S. Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev. Allergy Immunol., 2012;42:102-111
23. Ebringer A., Rashid T., Wilson C., Tiwana H., Green A. J., Thompson E. J., Chamoun V., Croker J. R., Binder A.: Multiple sclerosis, sporadic Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: are they autoimmune diseases evoked by Acinetobacter microbes showing molecular mimicry to brain antigens? J. Nutr. Environ. Med., 2004;14:293-302
24. Ebringer A., Wilson C.: HLA molecules, bacteria and autoimmunity. J. Med. Microbiol., 2000;49:305-311
25. Eisenbarth G. S.: Type 1 diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med., 1986;314:1360-1368
26. Enbom M., Wang F. Z., Fredrikson S., Martin C., Dahl H., Linde A.: Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin. Diagn. Lab. Immunol., 1999;6:545-549
27. Feltkamp T. E.: Factors involved in the pathogenesis of HLA-B27 associated arthritis. Scand. J. Rheumatol., 1995;24(Suppl.101):213-217
28. Fenalti G., Law R. H., Buckle A. M., Langendorf C., Tuck K., Rosado C. J., Faux N. G., Mahmood K., Hampe C. S., Banga J. P., Wilce M., Schmidberger J., Rossjohn J., El-Kabbani O., Pike R. N., Smith A. I., Mackay I. R., Rowley M. J., Whisstock J. C.: GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat. Struct. Mol. Biol., 2007;14:280-286
29. Fielder M., Pirt S. J., Tarpey I., Wilson C., Cunningham P., Ettelaie C., Binder A., Bansal S., Ebringer A.: Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett., 1995;369:243-248
30. Fu J., Jiang Y., Liang L., Zhu H.: Risk factors of primary thyroid dysfunction in early infants born to mothers with autoimmune thyroid disease. Acta Paediatr., 2005;94:1043-1048
31. Fujinami R. S., Oldstone M. B.: Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science, 1985;230:1043-1045
32. Futoma-Kołoch B., Bugla-Płoskońska G.: Efektywność bakteriobójczego działania surowicy wynikaja̧ca z obecności układu dopełniacza i lizozymu wobec bakterii, które unikaja̧ odpowiedzi immunologicznej organizmu. Postȩpy Hig. Med. Dośw., 2009;63:471-484
33. Garwolińska H.: Reaktywne zapalenie stawów - diagnostyka i obraz kliniczny. Alergia Astma Immunol., 1999;4:114-115
34. Gaston J.: Shigella induced reactive arthritis. Ann. Rheum. Dis., 2005;64:517-518
35. Glerum M., Robinson B. H., Martin J. M.: Could bovine serum albumin be the initiating antigen ultimately responsible for the development of insulin dependent diabetes mellitus? Diabetes Res., 1989;10:103-107
36. Gold R., Linington C., Lassmann H.: Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 2006;129:1953-1971
37. Górska S., Jarza̧b A., Gamian A.: Bakterie probiotyczne w przewodzie pokarmowym człowieka jako czynnik stymuluja̧cy układ odpornościowy. Postȩpy Hig. Med. Dośw., 2009;63:653-667
38. Granfors K.: Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease. J. Clin. Microbiol., 1979;9:336-341
39. Grus F. H., Joachim S. C., Hoffmann E. M., Pfeiffer N.: Complex autoantibody repertoires in patients with glaucoma. Mol. Vis., 2004;10:132-137
40. Guilherme L., Kalil J.: Rheumatic fever: the T cell response leading to autoimmune aggression in the heart. Autoimmun. Rev., 2002;1:261-266
41. Harrison L. C., Honeyman M. C.: Cow's milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes, 1999;48:1501-1507
42. Hiemstra H. S., Schloot N. C., van Veelen P. A., Willemen S. J., Franken K. L., van Rood J. J., de Vries R. R., Chaudhuri A., Behan P. O., Drijfhout J. W., Roep B. O.: Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA, 2001;98:3988-3991
43. Hirata D., Hirai I., Iwamoto M., Yoshio T., Takeda A., Masuyama J. I., Mimori A., Kano S., Minota S.: Preferential binding with Escherichia coli hsp60 of antibodies prevalent in sera from patients with rheumatoid arthritis. Clin. Immunol. Immunopathol., 1997;82:141-148
44. Hoff J. M., Daltveit A. K., Gilhus N. E.: Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology, 2003;61:1362-1366
45. Honeyman M. C., Coulson B. S., Stone N. L., Gellert S. A., Goldwater P. N., Steele C. E., Couper J. J., Tait B. D., Colman P. G., Harrison L. C.: Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes, 2000;49:1319-1324
46. Honeyman M. C., Stone N. L., Falk B. A., Nepom G., Harrison L. C.: Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J. Immunol., 2010;184:2204-2210
47. Honeyman M. C., Stone N. L., Harrison L. C.: T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol. Med., 1998;4:231-239
48. Huber A., Menconi F., Corathers S., Jacobson E. M., Tomer Y.: Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev., 2008;29:697-725
49. Hughes L. E., Bonell S., Natt R. S., Wilson C., Tiwana H., Ebringer A., Cunningham P., Chamoun V., Thompson E. J., Croker J., Vowles J.: Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neuroflament antibody index. Clin. Diagn. Lab. Immunol., 2001;8:1181-1188
50. Hughes L. E., Smith P. A., Bonell S., Natt R. S., Wilson C., Rashid T., Amor S., Thompson E. J., Croker J., Ebringer A.: Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Neuroimmunol., 2003;144:105-115
51. Hummel M., Füchtenbusch M., Schenker M., Ziegler A. G.: No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care, 2000;23:969-974
52. Im S. H., Barchan D., Feferman T., Raveh L., Souroujon M. C., Fuchs S.: Protective molecular mimicry in experimental myasthenia gravis. J. Neuroimmunol., 2002;126:99-106
53. Jaśkiewicz E.: Epitopy na białkach mieliny rozpoznawane przez autoprzeciwciała obecne u chorych na stwardnienie rozsiane. Postȩpy Hig. Med. Dośw., 2004;58:472-482
54. Jones D. B., Crosby I.: Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia, 1996;39:1318-1324
55. Karges W., Hammond-McKibben D., Gaedigk R., Shibuya N., Cheung R., Dosch H. M.: Loss of self-tolerance to ICA69 in nonobese diabetic mice. Diabetes, 1997;46:1548-1556
56. Karjalainen J., Martin J. M., Knip M., Ilonen J., Robinson B. H., Savilahti E., Akerblom H. K., Dosch H. M.: A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N. Engl. J. Med., 1992;327:302-307
57. Karlsen A. E., Dyrberg T.: Molecular mimicry between non-self, modifed self and self in autoimmunity. Semin. Immunol., 1998;10:25-34
58. Kaufman M., Gaydos C. A., Sriram S., Boman J., Tondella M. L., Norton H. J.: Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conficting results. Mult Scler., 2002;8:289-294
59. Kinsley G., Sieper J.: Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann. Rheum. Dis., 1996;55:564-584
60. Korzeniowska-Kowal A., Witkowska D., Gamian A.: Mimikra cza̧steczkowa bakteryjnych antygenów polisacharydowych i jej rola w etiologii chorób infekcyjnych i autoimmunologicznych. Postȩpy Hig. Med. Dośw., 2001;55:211-232
61. Kotb M.: Infection and autoimmunity: a story of the host, the pathogen and the copathogen. Clin. Immunol. Immunopathol., 1995;74:10-22
62. Kovvali G., Das K. M.: Molecular mimicry may contribute to pathogenesis of ulcerative colitis. FEBS Lett., 2005;579:2261-2266
63. Krȩtowski A.: Współczesne pogla̧dy na etiopatogenezȩ cukrzycy typu 1. Diabetologia Dośw. Klin., 2003;3:395-406
64. Kugelberg E., Gollan B., Tang C. M.: Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing. Vaccine, 2008;26(Suppl.8):134-139
65. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hämäläinen A. M., Korhonen S., Kimpimäki T., Sjöroos M., Ilonen J., Knip M., Simell O.: Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia, 2001;44:290-297
66. Kuwahara M., Suzuki S., Takada K., Kusunoki S.: Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol., 2011;239:87-90
67. Kwiatkowska B., Maślińska M.: Postȩpy w diagnostyce i leczeniu reaktywnego zapalenia stawów. Reumatologia, 2011;49:354-360
68. Lang P. A., Merkler D., Funkner P., Shaabani N., Meryk A., Krings C., Barthuber C., Recher M., Brück W., Häussinger D., Ohashi P. S., Lang K. S.: Oxidized ATP inhibits T-cell-mediated autoimmunity. Eur. J. Immunol., 2010;40:2401-2408
69. Lenz D. C, Lu L., Conant S. B., Wolf N. A., Gérard H. C., Whittum-Hudson J. A., Hudson A. P., Swanborg R. H.: A Chlamydia pneumoniaespecific peptide induces experimental autoimmune encephalomyelitis in rats. J. Immunol., 2001;167:1803-1808
70. Lévy-Marchal C., Karjalainen J., Dubois F., Karges W., Czernichow P., Dosch H. M.: Antibodies against bovine albumin and other diabetes markers in French children. Diabetes Care, 1995;18:1089-1094
71. Lewis K. A., Engle W., Hainline B. E., Johnson N., Corkins M., Eugster E. A.: Neonatal Graves' disease associated with severe metabolic abnormalities. Pediatrics, 2011;128:e232-e236
72. Libbey J. E., McCoy L. L., Fujinami R. S. Molecular mimicry in multiple sclerosis. Int. Rev. Neurobiol., 2007;79:127-147
73. Maclaren N. K., Alkinson M. A.: Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol. Med. Today, 1997;3:76-83
74. Mao Y. S., Lu C. Z., Wang X., Xiao B. G.: Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Exp. Neurol., 2007;206:231-239
75. Martin J. M., Trink B., Daneman D., Dosch H. M., Robinson B.: Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann. Med., 1991;23:447-452
76. McCarthy L. J., Danielson C. F., Fernandez C., Skipworth E., Limiac C. A., Prahlow T., Goldman J.: Intensive plasma exchange for severe autoimmune hemolytic anemia in a four-month-old infant. J. Clin. Apher., 1999;14:190-192
77. McCoy L., Tsunoda I., Fujinami R. S.: Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity, 2006;39:9-19
78. Milczarczyk A., Snarski E., Jȩdrzejczak W. W., Franek E.: Immunoablacja i przeszczepienie własnych komórek krwiotwórczych - nowa metoda leczenia świeżo rozpoznanej cukrzycy typu 1. Postȩpy Nauk Med., 2009;10:834-839
79. Miyazaki I., Cheung R. K., Gaedigk R., Hui M. F., Van der Meulen J., Rajotte R. V., Dosch H. M.: T cell activation and anergy to islet cell antigen in type I diabetes. J. Immunol., 1995;154:1461-1469
80. Munger K. L., De Lorenze G. N., Levin L. I., Rubertone M. V., Vogelman J. H., Peck C. A., Peeling R. W., Orentreich N., Ascherio A.: A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology, 2004;62:1799-1803
81. Nicolson G. L.: Systemic intracellular bacterial infections (Mycoplasma, Chlamydia, Borrelia species) in neurodegenerative (multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's) and behavioral (autistic spectrum disorders) diseases. www.townsendletter.com/April2008/systemicintracel- notes0408.htm (22.05.2012)
82. Norris J. M., Beaty B., Klingensmith G., Yu L., Hoffman M., Chase H. P., Erlich H. A., Hamman R. F., Eisenbarth G. S., Rewers M.: Lack of association between early exposure to cow's milk protein and β-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA, 1996;276:609-614
83. Ohashi P. S.: Negative selection and autoimmunity. Curr. Opin. Immunol., 2003;15:668-676
84. Ohteki T., Hessel A., Bachmann M. F., Zakarian A., Sebzda E., Tsao M. S., McKall-Faienza K., Odermatt B., Ohashi P. S.: Identification of a cross-reactive self ligand in virus mediated autoimmunity Eur. J. Immunol., 1999;29:2886-2896
85. Pak C. Y., Cha C. Y., Rajotte R. V., McArthur R. G., Yoon J. W.: Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia, 1990;33:569-572
86. Pak C. Y., Eun H. M., McArthur R. G., Yoon J. W.: Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet, 1988;1988, 1-4
87. Palmer J. P., Asplin C. M., Clemons P., Lyen K., Tatpati O., Raghu P. K., Paquette T. L.: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science, 1983;222:1337-1339
88. Paronen J., Knip M., Savilahti E., Virtanen S. M., Ilonen J., Akerblom H. K., Vaarala O.: Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes, 2000;49:1657-1665
89. Paxson J. A., Weber J. G., Kulczycki A. Jr.: Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes, 1997;46:1711-1717
90. Pearl A.: Autoimmunity. Methods and Protocols, Pathogenesis and Spectrum of Autoimmunity, 2004;1:1-8, wyd. Humana Press, Totowa, New Jersey
91. Persaud D. R., Barranco-Mendoza A.: Bovine serum albumin and insulin-dependent diabetes mellitus: is cow's milk still a possible toxicological causative agent of diabetes? Food Chem. Toxicol., 2004;42:707-714
92. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y. L., Martin S., Martin A., Powers A. C., Prochazka M., Naggert J., Leiter E. H., Eisenbarth G. S.: Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest., 1993;92:359-371
93. Poole B. D., Scofeld R. H., Harley J. B., James J. A.: Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity, 2006;39:63-70
94. Rabin D. U., Pleasic S. M., Shapiro J. A., Yoo-Warren H., Oles J., Hicks J. M., Goldstein D. E., Rae P. M.: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol., 1994;152:3183-3188
95. Ramos M., Alvarez I., Sesma L., Logean A., Rognan D., López de Castro J. A.: Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J. Biol. Chem., 2002;277:37573-37581
96. Ramos M., López de Castro J. A.: HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens, 2002;60:191-205
97. Ringrose J. H.: HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann. Rheum. Dis., 1999;58:598-610
98. Ringrose J. H., Muijsers A. O., Pannekoek Y., Yard B. A., Boog C. J., van Alphen L., Dankert J., Feltkamp T. E.: Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27. J. Med. Microbiol., 2001;50:385-389
99. Roep B. O., Hiemstra H. S., Schloot N. C., De Vries R. R., Chaudhuri A., Behan P. O., Drijfhout J. W.: Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann. N. Y. Acad. Sci., 2002;958:163-165
100. Rose N. R.: The role of infection in the pathogenesis of autoimmune disease. Semin. Immunol., 1998;10:5-13
101. Sarvetnick N., Ohashi P. S.: Autoimmunity. Curr. Opin. Immunol., 2003;15:647-650
102. Saukkonen T., Savilahti E., Vaarala O., Virtala E. T., Tuomilehto J., Akerblom H. K.: Children with newly diagnosed IDDM have increased levels of antibodies to bovine serum albumin but not to ovalbumin. Childhood Diabetes in Finland Study Group. Diabetes Care, 1994;17:970-976
103. Schrezenmeir J., Jagla A.: Milk and diabetes. J. Am. Col. Nutr., 2000;19(Suppl.2):176S-190S
104. Schwimmbeck P. L., Dyrberg T., Drachman D. B., Oldstone M. B.: Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J. Clin. Invest., 1989;84:1174-1180
105. Schwimmbeck P. L., Yu D. T., Oldstone M. B.: Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J. Exp. Med., 1987;166:173-181
106. Seissler J., Hatziagelaki E., Scherbaum W. A.: Modern concepts for the prediction of type 1 diabetes. Exp. Clin. Endocrinol. Diabetes, 2001;109(Suppl.2):S304-S316
107. Sfriso P., Ghirardello A., Botsios C., Tonon M., Zen M., Bassi N., Bassetto F., Doria A.: Infections and autoimmunity: the multifaceted relationship. J. Leukoc. Biol., 2010;87:385-395
108. Shahrizaila N., Yuki N.: Guillain-Barré syndrome animal model: The first proof of molecular mimicry in human autoimmune disorder. J. Biomed. Biotechnol., 2011;2011:829128
109. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., Cutolo M., Amital H., Levy Y., Abu-Shakra M., Barzilai O., Berkun Y., Blank M., de Carvalho J. F., Doria A., Gilburd B., Katz U., Krause I., Langevitz P., Orbach H., Pordeus V., Ram M., Toubi E., Sherer Y.: The mosaic of autoimmunity: hormonal and enviromental factors involved in autoimmune diseases - 2008. Isr. Med. Assoc. J., 2008;10:8-12
110. Sibilia J., Limbach F. X.: Reactive arthritis or chronic infectious arthritis? Ann. Rheum. Dis., 2002;61:580-587
111. Sieper J., Braun J.: Pathogenesis of spondyloarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum., 1995;38:1547-1554
112. Smolewska E.: Znaczenie infekcji w chorobach autoimmunologicznych. Reumatologia, 2009;47:332-338
113. Söderström M.: Clues to the immunopathogenesis of multiple sclerosis by investigating untreated patients during the very early stage of disease. Neurol. Sci., 2001;22:145-149
114. Söderberg-Nauclér C.: Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus. Arthritis Res. Ther., 2012, 14:101
115. Soldan S. S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P. A., Brennan M. B., Maloni H. W., McFarland H. F., Lin H. C., Patnaik M., Jacobson S.: Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med., 1997;3:1394-1397
116. Soltész G.: Diabetes in the young: a pediatric and epidemiological perspective. Diabetologia, 2003;46:447-454
117. Sriram S., Stratton C. W., Yao S., Tharp A., Ding L., Bannan J. D., Mitchell W. M.: Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol., 1999;46:6-14
118. Stieglitz H., Lipsky P.: Association between reactive arthritis and antecedent infection with Shigella flexneri carrying a 2-Md plasmid and encoding an HLA-B27 mimetic epitope. Arthritis Rheum., 1993;36:1387-1391
119. Szajewska H., Chmielewska A.: Powikłania zakażenia rotawirusowego - przegla̧d piśmiennictwa. Pediatria Współczesna, 2008;10:7-11
120. Świerkot J., Szechiński J.: Reaktywne zapalenia stawów - problemy diagnostyczne i terapeutyczne. Przew. Lek., 2003;6:74-83
121. Taurog J. D.: Arthritis in HLA-B27 transgenic animals. Am. J. Med. Sci., 1998;316:250-256
122. Tejada-Simon M. V., Zang Y. C., Hong J., Rivera V. M., Zhang J. Z.: Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann. Neurol., 2003;53:189-197
123. Tomer Y.: Hepatitis C and interferon induced thyroiditis. J. Autoimmun., 2010;34:J322-J326
124. Tutaj M., Szczepanik M.: Mechanizmy regulacji odpowiedzi immunologicznej w modelu stwardnienia rozsianego u myszy. Postȩpy Hig. Med. Dośw., 2006;60:571-583
125. van der Werf N., Kroese F. G., Rozing J., Hillebrands J. L.: Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev., 2007;23:169-183
126. Varela-Calvino R., Skowera A., Arif S., Peakman M.: Identification of a naturally processed cytotoxic CD8 T-cell epitope of Coxsackie virus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein. J. Virol., 2004;78:13399-13408
127. Virtanen S. M., Saukkonen T., Savilahti E., Ylönen K., Räsänen L., Aro A., Knip M., Tuomilehto J., Akerblom H. K.: Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children. Diabetologia, 1994;37:381-387
128. Wekerle H., Hohlfeld R.: Molecular mimicry in multiple sclerosis. N. Engl. J. Med., 2003;349:185-186
129. Westall F. C.: Molecular mimicry revisited: gut bacteria and multiple sclerosis. J. Clin. Microbiol., 2006;44:2099-2104
130. WHO: Diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/index. html (01.02.2012)
131. Winer S., Astsaturov I., Gaedigk R., Hammond-McKibben D., Pilon M., Song A., Kubiak V., Karges W., Arpaia E., McKerlie C., Zucker P., Singh B., Dosch H. M.: ICA69null nonobese diabetic mice develop diabetes, but resist disease acceleration by cyclophosphamide. J. Immunol., 2002;168:475-482
132. Witkowska D.: Mimikra cza̧steczkowa jako czynnik patogenności bakterii. Postȩpy Hig. Med. Dośw., 1999;53:545-559
133. Witkowska D., Bartyś A., Gamian A.: Białka osłony komórkowej pałeczek jelitowych i ich udział w patogenności oraz odporności przeciwbakteryjnej. Postȩpy Hig. Med. Dośw., 2009;63:176-199
134. Wucherpfennig K. W., Strominger J. L.: Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell, 1995;80:695-705
135. Za̧bek J.: Rola antygenów bakteryjnych w indukcji procesów autoimmunizacyjnych zwia̧zanych z patogeneza̧ reaktywnego zapalenia stawów. Alergia Astma Immunologia, 1999;4:41-44
136. Zhang H., Kaur I., Niesel D. W., Seetharamaiah G. S., Peterson J. W., Prabhakar B. S., Klimpel G. R.: Lipoprotein from Yersinia enterocolitica contains epitopes that crossreact with the human thyrotropin receptor. J. Immunol., 1997;158:1976-1983
137. Zhang H., Kaur I., Niesel D. W., Seetharamaiah G. S., Peterson J. W., Justement L. B., Prabhakar B. S., Klimpel G. R.: Yersinia enterocolitica envelope proteins that are crossreactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activity. J. Autoimmun., 1996;9:509-516